Dane Leone

Stock Analyst at Raymond James

(0)
# 3802
Out of 5,298 analysts
128
Total ratings
32.65%
Success rate
-5.38%
Average return
42 Stocks
Name Action Price Target Current % Upside Ratings Updated
XLO Xilio Therapeutics
Maintains: Outperform
6 4
0.69 479.71% 3 Nov 8, 2024
RGNX Regenxbio
Reinstates: Outperform
45
6.34 609.78% 2 Feb 21, 2024
BPMC Blueprint Medicines
Maintains: Strong Buy
85 100
80.28 24.56% 9 Dec 22, 2023
RVMD Revolution Medicines
Initiates Coverage On: Outperform
30
31.27 -4.06% 1 Nov 16, 2023
BLUE bluebird bio
Maintains: Outperform
200 260
4.83 5283.02% 6 Nov 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
950
585.51 62.25% 10 Nov 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 9
n/a n/a 3 Oct 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Strong Buy
13
1.61 707.45% 5 Oct 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
29 46
31.7 45.11% 2 Jul 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
69
23.69 191.26% 5 May 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
24 8
n/a n/a 5 May 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Strong Buy
29
2.08 1294.23% 2 Apr 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
5 8
1.47 444.22% 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
29 14
6.46 116.72% 5 Nov 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Strong Buy
58
8.55 578.36% 4 Oct 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
54 70
25.19 177.89% 3 Aug 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 6 Aug 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
54 63
37.13 69.67% 2 Aug 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Jun 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Apr 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
24 6
n/a n/a 2 Mar 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
50 65
47.16 37.83% 3 Oct 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 5 Dec 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
255
296.5 -14% 3 Oct 26, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
n/a
n/a n/a 5 Dec 21, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
32
3.06 945.75% 2 Sep 10, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Aug 28, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 2 Jul 21, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
n/a
n/a n/a 3 Jun 8, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
58
n/a n/a 1 Dec 22, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 4, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 1, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
n/a n/a 1 Sep 23, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Sep 7, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 1 Sep 5, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Aug 25, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 1 Aug 24, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
n/a
n/a n/a 1 Aug 24, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 2 Aug 24, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Terminates Coverage On:
n/a
n/a n/a 1 Aug 15, 2016
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
n/a n/a 1 Aug 11, 2016